I agree that this site is using cookies. You can find further informations here.
X
Aljayyoussi, Ghaith
127  results:
Search for persons X
?
1

Riboswitch-controlled IL-12 gene therapy reduces hepatocell..:

Düchs, Matthias J. ; Kratzer, Ramona F. ; Vieyra-Garcia, Pablo...
Frontiers in Immunology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Combinations of the azaquinazoline anti-Wolbachia agent, AW..:

Hegde, Shrilakshmi ; Marriott, Amy E. ; Pionnier, Nicolas...
Frontiers in Microbiology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
3

Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome..:

Jeffreys, Laura N. ; Ardrey, Alison ; Hafiz, Taghreed A....
ACS Infectious Diseases.  9 (2023)  2 - p. 221-238 , 2023
Link: https://doi.org/10.1021/..
 
?
4

The Parasite Reduction Ratio (PRR) Assay Version 2: Standar..:

Walz, Annabelle ; Duffey, Maëlle ; Aljayyoussi, Ghaith...
Pharmaceuticals.  16 (2023)  2 - p. 163 , 2023
Link: https://doi.org/10.3390/..
 
?
5

Remdesivir–ivermectin combination displays synergistic inte..:

Jeffreys, Laura N. ; Pennington, Shaun H. ; Duggan, Jack...
International Journal of Antimicrobial Agents.  59 (2022)  3 - p. 106542 , 2022
Link: https://doi.org/10.1016/..
 
?
6

SARS-CoV-2 viability on sports equipment is limited, and de..:

Edwards, Thomas ; Kay, Grant A. ; Aljayyoussi, Ghaith...
Scientific Reports.  12 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
7

Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-..:

Byrne, Rachel L. ; Kay, Grant A. ; Kontogianni, Konstantina...
Emerging Infectious Diseases.  26 (2020)  11 - p. 2769-2770 , 2020
Link: https://doi.org/10.3201/..
 
?
8

Therapeutic Potential of Nitazoxanide: An Appropriate Choic..:

Stachulski, Andrew V. ; Taujanskas, Joshua ; Pate, Sophie L....
ACS Infectious Diseases.  7 (2020)  6 - p. 1317-1331 , 2020
Link: https://doi.org/10.1021/..
 
?
9

Auto-fluorescent PAMAM-based dendritic molecules and their ..:

El-Betany, Alaa M.M. ; Kamoun, Elbadawy A. ; James, Craig...
International Journal of Pharmaceutics.  579 (2020)  - p. 119187 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 ..:

Rajoli, Rajith K. R. ; Pertinez, Henry ; Arshad, Usman...
British Journal of Clinical Pharmacology.  87 (2020)  4 - p. 2078-2088 , 2020
Link: https://doi.org/10.1111/..
 
?
11

Prioritization of Anti‐SARS‐Cov‐2 Drug Repurposing Opportun..:

Arshad, Usman ; Pertinez, Henry ; Box, Helen...
Clinical Pharmacology & Therapeutics.  108 (2020)  4 - p. 775-790 , 2020
Link: https://doi.org/10.1002/..
 
?
12

Short-course, oral flubendazole does not mediate significan..:

Sjoberg, Hanna T. ; Pionnier, Nicolas ; Aljayyoussi, Ghaith...
PLOS Neglected Tropical Diseases.  13 (2019)  1 - p. e0006356 , 2019
Link: https://doi.org/10.1371/..
 
?
13

AWZ1066S, a highly specific anti-Wolbachia drug candidate f..:

Hong, W. David ; Benayoud, Farid ; Nixon, Gemma L....
Proceedings of the National Academy of Sciences of the United States of America.  116 (2019)  4 - p. 1414-1419 , 2019
Link: https://www.jstor.org/st..
 
?
14

Intracellular PD Modelling (PDi) for the Prediction of Clin..:

Aljayyoussi, Ghaith ; Donnellan, Samantha ; Ward, Stephen A..
Pharmaceutics.  11 (2019)  6 - p. 278 , 2019
Link: https://doi.org/10.3390/..
 
?
15

Treatment responses to Azithromycin and Ciprofloxacin in un..:

Jin, Celina ; Gibani, Malick M. ; Pennington, Shaun H....
PLOS Neglected Tropical Diseases.  13 (2019)  12 - p. e0007955 , 2019
Link: https://doi.org/10.1371/..
 
1-15